Discharge from ED is Generally Appropriate for Acute Gout with CRP 28 mg/L
Yes, discharge from the emergency department is appropriate for most patients with acute gout and a CRP of 28 mg/L, provided septic arthritis has been adequately excluded and the patient can tolerate oral anti-inflammatory therapy. A CRP of 28 mg/L, while elevated, is consistent with the expected acute phase response in gout and does not automatically necessitate admission 1.
Key Clinical Decision Points
Rule Out Septic Arthritis First
The primary concern with elevated inflammatory markers in monoarticular or oligoarticular arthritis is distinguishing gout from septic arthritis. While CRP elevation is expected in acute gout 1, you must:
- Perform arthrocentesis when feasible to confirm MSU crystals and exclude infection
- Consider that severe polyarticular gout can mimic sepsis with extreme inflammatory markers (CRP >47 mg/dl reported) 2
- Note that only 8% of ED gout visits include arthrocentesis, though crystal-proven diagnosis is ideal 3
Initiate Appropriate Anti-Inflammatory Treatment
The cornerstone of ED management is starting anti-inflammatory therapy before discharge 4. According to ACP guidelines, choose from:
- Corticosteroids (oral prednisone or IM injection)
- NSAIDs (if renal function permits)
- Low-dose colchicine (strong recommendation for low-dose regimen) 4
The concerning reality: during >50% of ED visits for gout, anti-inflammatory drugs are not given during the visit 3, and only 28% of patients receive prescriptions for anti-inflammatory medications 5. This represents a significant quality gap.
Discharge Criteria
Discharge is appropriate when:
- Septic arthritis has been reasonably excluded
- Patient can take oral medications
- Pain is manageable or improving with initial treatment
- No signs of systemic sepsis beyond expected gout inflammation
- Adequate follow-up can be arranged
The CRP 28 mg/L Context
A CRP of 28 mg/L falls within the range of acute gout flares. Research shows even mildly elevated CRP (5-25 mg/L) predicts 7-day ED revisit 6, but this reflects disease severity rather than need for admission. The acute phase response in gout resolves rapidly with treatment 1.
Critical Post-Discharge Management
Immediate Follow-Up (Within 30 Days)
Current data reveals only 21.3% of patients have gout-specific follow-up within 30 days of ED discharge 5. Arrange definitive follow-up before discharge to address:
- Treatment response assessment
- Serum urate testing (38% get tested within 6 months) 5
- Discussion of urate-lowering therapy for recurrent disease
Avoid Common Pitfalls
- Do not start urate-lowering therapy during acute flare - this can worsen the attack 4, 7
- Do not discharge without anti-inflammatory medication - 6% of patients receive neither ED treatment nor prescription 3
- Do not prescribe opioids as monotherapy - 10.3% fill opioid prescriptions post-discharge, but these don't treat inflammation 5
Address the High Representation Rate
Be aware that 29.9% of patients return to ED within 90 days, with 9.4% specifically for gout 5. Another study found 18.8% representation rate 8. This high rate reflects:
- Inadequate initial treatment
- Poor medication adherence
- Lack of urate-lowering therapy in chronic disease (only 30.8% of patients with prior gout history are on ULT) 8
When to Consider Admission
Admission may be warranted for:
- Inability to exclude septic arthritis
- Intractable pain despite parenteral therapy
- Inability to take oral medications
- Severe polyarticular involvement mimicking sepsis 2
- Significant acute kidney injury complicating treatment 2
- Social factors preventing adequate outpatient management
Note that only 5% of acute gout ED visits result in hospitalization 3, confirming that outpatient management is standard for the vast majority of cases.